Insider Transactions in Q1 2021 at Biora Therapeutics, Inc. (BIOR)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2021
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,608
-1.71%
|
$6,432
$4.05 P/Share
|
|
Mar 04
2021
|
Matthew T Cooper General Manager, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,609
-3.16%
|
$6,436
$4.05 P/Share
|
|
Mar 04
2021
|
George Gianakopoulos Senior Vice President of Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
490
-2.2%
|
$1,960
$4.05 P/Share
|
|
Mar 04
2021
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
1,564
-2.99%
|
$6,256
$4.05 P/Share
|
|
Mar 04
2021
|
Sami Shihabi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,623
-6.96%
|
$10,492
$4.05 P/Share
|
|
Feb 15
2021
|
Matthew T Cooper General Manager, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
662
-1.28%
|
$3,310
$5.6 P/Share
|
|
Feb 15
2021
|
Eric D Esparbes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,361
-5.39%
|
$26,805
$5.6 P/Share
|
|
Feb 15
2021
|
George Gianakopoulos Senior Vice President of Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
377
-1.66%
|
$1,885
$5.6 P/Share
|
|
Feb 15
2021
|
Clarke Neumann |
SELL
Payment of exercise price or tax liability
|
Direct |
663
-1.25%
|
$3,315
$5.6 P/Share
|
|
Feb 15
2021
|
Sami Shihabi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
932
-2.41%
|
$4,660
$5.6 P/Share
|
|
Feb 15
2021
|
Harry Stylli Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,287
-0.08%
|
$56,435
$5.6 P/Share
|